Sorafenib Tosylate

CAS 475207-59-1 16 current records 2 historicalSmall Molecule

Who holds supplier records for Sorafenib Tosylate? 16 organisations hold a current record for Sorafenib Tosylate: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 13 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (10), China (5) and Netherlands (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Sorafenib Tosylate: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/sorafenib-tosylate

Reading the evidence

  • 16 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in India

    10 of the 16 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.

  • 10 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (16)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Sorafenib Tosylate. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Sorafenib Tosylate sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (13)

Certificates of Suitability on the EDQM register for Sorafenib Tosylate, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 17 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
MSN LABORATORIES PRIVATE LIMITED SangareddyIN
CEP 2023-185 - Rev 03
Sorafenib tosilate, Form-I, micronised and non-micronised
Nov 2026Inspected Aug 2026
Slovakia
TAPI NL B.V. AmsterdamNL
CEP 2021-247 - Rev 03
Sorafenib tosilate
Jun 2026—
CIPLA LIMITED MumbaiIN
CEP 2024-167 - Rev 00
Sorafenib tosilate
Feb 2026—
KINHOO PHARMACEUTICAL CO., LTD. ZhuhaiCN
CEP 2024-398 - Rev 00
Sorafenib tosilate
Feb 2026—
GRANULES INDIA LIMITED HyderabadIN
CEP 2022-386 - Rev 01
Sorafenib tosilate
Oct 2025—
HETERO LABS LIMITED HyderabadIN
CEP 2021-324 - Rev 02
Sorafenib tosilate, Form-III
Jul 2025—
SHILPA PHARMA LIFESCIENCES LIMITED RaichurIN
CEP 2022-056 - Rev 01
Sorafenib tosilate
Jun 2025—
BDR LIFESCIENCES PRIVATE LIMITED Luna VillageIN
CEP 2022-478 - Rev 01
Sorafenib tosilate
Jun 2025Inspected Jul 2025
Hungary
CHONGQING CARELIFE PHARMACEUTICAL CO., LTD. ChongqingCN
CEP 2023-373 - Rev 00
Sorafenib tosilate
May 2025—
SHANDONG ANHONG PHARMACEUTICAL CO., LTD. Dezhou CityCN
CEP 2023-250 - Rev 02
Sorafenib tosilate, Micronised, polymorphic form I
May 2025Inspected Nov 2025
Greece
SHANDONG LONCOM PHARMACEUTICAL CO., LTD DezhouCN
CEP 2023-464 - Rev 00
Sorafenib tosilate
Apr 2025—
APITORIA PHARMA PRIVATE LIMITED HyderabadIN
CEP 2022-061 - Rev 01
Sorafenib tosilate
Dec 2023—
ALEMBIC PHARMACEUTICALS LIMITED VadodaraIN
R0-CEP 2022-231 - Rev 00
Sorafenib tosilate
Jun 2023—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (2)

Organisations whose Type II DMFs for Sorafenib Tosylate are no longer active. These show a past filing, not current supply.

Show all 2 historical records
  • Zhejiang Jiuzhou Pharmaceutical Co., Ltd.
    China · Inactive DMF 27793 · filed Nov 2013
  • Sichuan Xieli Pharmaceutical Co Ltd
    China · Inactive DMF 26460 · filed Sept 2012

Other forms of this substance

A DMF or CEP is listed under the form it names. Salts, esters and hydrates of the same active substance have their own records:

Overview

Sorafenib Tosylate is a small molecule active pharmaceutical ingredient (ChEMBL CHEMBL1200485).

Chemical identity

IUPAC name
4-[4-[[4-chloro-3-(trifluoromethyl)phenyl]carbamoylamino]phenoxy]-N-methylpyridine-2-carboxamide;4-methylbenzenesulfonic acid
Canonical SMILES
CC1=CC=C(C=C1)S(=O)(=O)O.CNC(=O)C1=NC=CC(=C1)OC2=CC=C(C=C2)NC(=O)NC3=CC(=C(C=C3)Cl)C(F)(F)F
InChIKey
IVDHYUQIDRJSTI-UHFFFAOYSA-N
Synonyms
BAY 54-9085, BAY-54-9085, Nexavar, Sorafenib accord, Sorafenib tosilate, Sorafenib tosylate, NSC724772, BAY 43-9006 tosylate, CHEBI:50928, RefChem:57444, Sorafenib tosylate [USAN], Sorafenib (Tosylate)

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Kinase Inhibitor
Mechanism of action
Protein Kinase Inhibitors

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Sorafenib Tosylate?

16 organisations hold an active US FDA Type II Drug Master File or a CEP for Sorafenib Tosylate: Alembic Pharmaceuticals Limited (India), MSN Laboratories Private Limited (India), APITORIA PHARMA PRIVATE LTD (India), CHONGQING CARELIFE PHARMACEUTICAL CO LTD (China), Cipla Limited (India), Granules India Limited (India), Hetero Labs Limited (India) and Shandong Loncom Pharmaceutical Co.,ltd. (China), and 8 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Sorafenib Tosylate Drug Master Files are active?

Alembic Pharmaceuticals Limited (DMF 34138, 29941), MSN Laboratories Private Limited (DMF 33727, 30180), APITORIA PHARMA PRIVATE LTD (DMF 36671), CHONGQING CARELIFE PHARMACEUTICAL CO LTD (DMF 32840), Cipla Limited (DMF 32642, 38033), Granules India Limited (DMF 37229), Hetero Labs Limited (DMF 30235) and Shandong Loncom Pharmaceutical Co.,ltd. (DMF 44130) and 4 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Sorafenib Tosylate records mean?

2 organisations have only inactive Type II DMFs for Sorafenib Tosylate. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Sorafenib Tosylate have a European Certificate of Suitability?

Yes. 13 organisations hold a valid CEP for Sorafenib Tosylate on the EDQM register, including MSN LABORATORIES PRIVATE LIMITED Sangareddy (IN), TAPI NL B.V. Amsterdam (NL), CIPLA LIMITED Mumbai (IN), KINHOO PHARMACEUTICAL CO., LTD. Zhuhai (CN), GRANULES INDIA LIMITED Hyderabad (IN) and HETERO LABS LIMITED Hyderabad (IN) and 7 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Sorafenib Tosylate supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Sorafenib Tosylate?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.